Explore Fidelity's robust five-step investment process for fixed income. Beginning with macro analysis, the approach prioritizes risk-adjusted returns. Collaborating with macro research analysts, the ...
Precision Biosciences stock (ticker: DTIL) went public in late March and Fidelity Investments’ independent venture-capital arm found itself with tens of millions of dollars in paper profits.
The wave of cash that has been lifting all boats in the gene-editing pool has now raised a new biotech into view. Precision BioSciences, a Duke spinout focused on competing in the fractious and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback